PROactive Solutions for Prolonging Resilience (PROSPR)
ID: ARPA-H-SOL-25-125Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Washington, DC, 20005, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
  1. 1
    Posted Dec 23, 2024, 12:00 AM UTC
  2. 2
    Updated Apr 4, 2025, 12:00 AM UTC
  3. 3
    Due May 23, 2025, 6:00 PM UTC
Description

The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at developing interventions to extend the healthspan of Americans by addressing age-related health decline. This initiative seeks to negotiate multiple Other Transaction Agreements (OTs) with eligible entities, focusing on three key technical areas: the development of an intrinsic capacity score, repurposing FDA-approved interventions, and creating second-generation interventions. The program is significant for transforming geriatric medicine into a preventive care model, emphasizing health equity and proactive health management for aging populations. Interested proposers can find further details and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with key deadlines for proposal submissions set for April and May 2025.

Point(s) of Contact
The PROSPR Team
PROSPR@arpa-h.gov
Files
Title
Posted
Apr 4, 2025, 7:08 PM UTC
The document outlines the ARPA-H solicitation for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending the healthspan of Americans by developing interventions that target the underlying causes of age-related health decline. The program includes establishing a predictive Intrinsic Capacity (IC) score, repurposing FDA-approved drugs, and testing second-generation interventions. The structured approach spans multiple technical areas over a five-year timeline, each with specific objectives, metrics, and phases, and engaging multidisciplinary teams to encourage collaboration. Key milestones include developing in-home assessment technologies, conducting decentralized clinical trials, and ensuring accessibility in health interventions. The program's ultimate goal is to create innovative preventative care models that reduce healthcare costs associated with chronic diseases while improving overall well-being for aging populations. Interested proposers are encouraged to attend a Proposers’ Day and submit questions via designated channels to promote participation and engagement.
Apr 4, 2025, 9:04 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has issued a final Innovative Solutions Opening (ISO) titled "PROactive Solutions for Preserving Resilience" (PROSPR). The program aims to extend the healthspan of Americans by developing preventative interventions targeting the underlying causes of age-related health decline. Proposals are sought from eligible entities to negotiate multiple Other Transaction Agreements (OTs). The solicitation covers detailed program information, eligibility, submission, evaluation processes, and general requirements for proposers. The PROSPR program has a five-year scope and focuses on three technical areas: 1) development of an intrinsic capacity score to evaluate health outcomes, 2) repurposing FDA-approved interventions, and 3) creating second-generation interventions. Each area includes defined phases for development, trials, and metrics to measure progress. The program aims to transform geriatric medicine into a preventive care model, emphasizing accessibility and health equity. With a variety of innovative deliverables and collaborative approaches, PROSPR seeks to tackle the significant economic burden of chronic diseases and enhance proactive health management for aging populations. Key deadlines for submission are set for April and May 2025, and interested proposers can find more information on the ARPA-H website.
Apr 4, 2025, 9:04 PM UTC
The ARPA-H Model Other Transaction Agreement pertains to the PROactive Solutions for Prolonging Resilience (PROSPR) program, which aims to develop interventions to extend healthspan by 20 years, addressing age-related health loss. The sample agreement outlines the terms and conditions for federal funding and project execution details, including project duration, management structure, deliverables, and financial obligations. Key components include the expectation for the Performer to manage the project, report milestones, and ensure compliance with regulations, particularly regarding human subjects and intellectual property rights. The agreement also details the Government's rights over inventions and data generated, emphasizing a collaborative approach while allowing flexibility for modifications. Lastly, the document emphasizes the importance of protecting intellectual property, especially regarding foreign access and security. This agreement serves as a framework for expedited negotiations for potential project awards, ensuring clarity in roles, responsibilities, and expected outcomes in advancing aging-related health interventions within a structured federal funding context.
Apr 4, 2025, 9:04 PM UTC
The document outlines a federal government Request for Proposal (RFP) focused on cost proposal submissions by potential contractors. Its primary purpose is to guide proposers in developing, structuring, and providing thorough cost proposals that will be assessed by government officials during the evaluation process. Key elements include a detailed breakdown of projected costs, such as direct labor, general and administrative (G&A), subcontractors, consultants, and other direct costs. The document stresses the importance of justifying cost estimates and requires proposers to offer a clear explanation and evidence supporting their suggested expenses. Proposers must complete various tabs in the provided spreadsheet for different periods, including cost summaries for each task in the statement of work, ensuring that all expenses align with the total amounts submitted. Furthermore, the document emphasizes that all cost entries need to be precise and reconciled across worksheets to facilitate a streamlined evaluation and negotiation if selected for contract award. Important considerations such as fiscal year definitions and applicable labor categories are also outlined, highlighting the significance of adhering to federal guidelines and standards in proposal submissions. Overall, the document serves as a comprehensive guide enhancing transparency and consistency in the RFP process.
Lifecycle
Title
Type
Similar Opportunities
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
ADAPT Contract Research Organization Support Services
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for Contract Research Organization (CRO) support services under the ADAPT Contract Research Organization Support Services initiative. This program aims to enhance cancer treatment strategies by developing an adaptive cancer treatment platform that integrates advanced analysis techniques and biomarker discovery to improve patient outcomes for metastatic cancers. The selected contractor will manage clinical trial data, conduct biological assays, and ensure compliance with regulatory standards, with a contract period of one year and four optional renewal years. Proposals are due by April 18, 2025, at 1:00 PM ET, and interested parties should direct inquiries to Steven Snyder at steven.snyder@arpa-h.gov or Clare Sanchez at clare.sanchez@arpa-h.gov.
Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) under the Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. This initiative aims to significantly enhance the speed and accuracy of diagnosing rare diseases, which affect approximately 30 million Americans, by developing innovative diagnostic support tools and a sustainable data platform optimized for AI-driven solutions. The RAPID program encompasses two phases over 4.5 years, focusing on extensive data curation, multimodal patient data collections, and the establishment of an AI-driven data commons, with the goal of reducing diagnostic delays and improving health management for underserved populations. Proposals are due by April 24, 2025, and interested parties can direct inquiries to the RAPID Email Box at RAPID@ARPA-H.gov.
Ocular Laboratory for Analysis of Biomarkers (OCULAB)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative, aimed at advancing the diagnosis and treatment of ocular conditions, particularly dry eye disease (DED). This program invites innovative solutions to develop a continuous monitoring biosensor integrated with therapeutic delivery systems, leveraging AI for non-invasive treatment methods. The initiative emphasizes collaboration among commercial and academic entities to enhance healthcare access and patient outcomes, with multiple awards anticipated based on scientific merit. Interested parties can contact the OCULAB Team at OCULAB@ARPA-H.gov for further information, with key proposal deadlines and requirements outlined in the associated documents.
ARPA-H ImagiNg Data EXchange (INDEX)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program, aimed at developing a sustainable platform to enhance access to medical imaging data. This initiative seeks to address the growing demand for imaging services and the shortage of qualified radiologists by leveraging artificial intelligence and machine learning to streamline data management and analysis. The program is structured in two phases: Phase 0 focuses on business model development, while Phase 1 involves system design and participant enrollment, with an emphasis on ensuring diverse and representative datasets. Interested parties should submit their proposals by April 21, 2025, and can direct inquiries to the INDEX Team at INDEX@arpa-h.gov.
Chemistries and monoLayers for Anti-aging Kinematics (CLOAK)
Buyer not available
The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for the Chemistries and monoLayers for Anti-aging Kinematics (CLOAK) project, aimed at enhancing the longevity and performance of microelectromechanical systems (MEMS) critical for precision positioning and navigation. This initiative seeks innovative solutions to address sensor drift and aging issues in MEMS, which are vital for operational reliability in GPS-denied environments, with a focus on achieving less than 10% performance degradation in Phase 1 and over 10 years of operation with ideally no degradation in Phase 2. Proposals must comply with DARPA's submission standards and include detailed cost breakdowns, with a total funding amount of up to $1.2 million available across two phases. Interested parties must submit their proposals by April 14, 2025, and can contact the BAA Coordinator at CLOAK@darpa.mil for further information.
A Human Multi-Organ Tissue Equivalent Platform to Model High Consequence Threat Agents
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking a contractor to develop a Human Multi-Organ Tissue Equivalent Platform aimed at modeling high consequence threat agents. This initiative focuses on creating a micro-engineered organ/tissue equivalent platform that will facilitate the modeling of pathogenic outcomes from emerging infectious diseases and the testing of medical countermeasures, particularly for respiratory viruses such as SARS-CoV-2, MERS, and pandemic H1N1 influenza. The project is critical for enhancing the military's capability to protect warfighters from both natural and manmade threats, ensuring rapid identification of effective medical responses. Interested contractors must submit their capabilities by 10:00 AM EST on April 14, 2025, and can direct inquiries to Kirstin L. Quinn at Kirstin.L.Quinn.civ@health.mil.